Shandong Weigao Group Medical Polymer Company Limited (1066) convened an extraordinary general meeting on 12 February 2026, where shareholders voted on a resolution concerning the Sale and Purchase Agreement (including its original and supplemental versions), the Compensation Agreement, and the Letter of Non-Competition Undertakings linked to transactions dated 5 January 2026. The resolution secured approval by way of poll.

The final tally showed approximately 88.98% of the votes (1,445,823,676 shares) cast in favor and 11.02% (179,089,836 shares) against, exceeding the simple majority requirement. A group of related individuals and their associates abstained from voting on the proposal.

The total number of shares eligible to vote at the meeting was 2,366,794,648 H shares. No voting rights were exercised from 41,130,000 treasury shares. All directors except one were in attendance, and the voting process was independently scrutinized by Weihai Langpu United Certified Public Accountants (General Partnership).